DANIELLE SABATINI: Open Payments
NPI 1144549163 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 7 companies in 2025. Trend: 2023 $207 · 2024 $0 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $68 |
| Astellas Pharma US Inc | 2 | $49 |
| ABBVIE INC. | 2 | $42 |
| Amgen Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $23 |
| Abbott Laboratories | 1 | $19 |
| Corcept Therapeutics | 1 | $14 |
Products named: Veozah, Ozempic, MOUNJARO, QULIPTA, EVENITY, FREESTYLE LIBRE 3, VRAYLAR, OTEZLA.
Industry payments across FL — which companies pay providers there.
